Kyntra Bio to Report First Quarter 2026 Financial Results

Go back to Kyntra Bio to Report First Quarter 2026 Financial Results
(NASDAQ: KYNB) Delayed: 7.27 +0.29 (4.15%)
Previous Close $6.98    52 Week High
Open $6.97    52 Week Low
Day High $7.30    P/E N/A 
Day Low $6.97    EPS
Volume 5,203